Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL583686 | 0.91 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL1616027 | 0.90 | TSHR (0.33) | CYP1A2 | |
| SCHEMBL1617542 | 0.87 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL2357386 | 0.85 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL3409194 | 0.84 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL110176 | 0.80 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL1617094 | 0.79 | — | — | |
| SCHEMBL1617271 | 0.79 | — | — | |
| SCHEMBL1617792 | 0.79 | CNR1 (0.30) | — | |
| SCHEMBL1617802 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041726-A1 | FOAMABLE COMPOSITION, USE THEREOF, AND PROCESS FOR ITS PREPARATION | CHATTEM, INC. | 2024-02-08 | — | — | US | claimed |
| EP-4231985-A1 | FOAMABLE COMPOSITION, USE THEREOF, AND PROCESS FOR ITS PREPARATION | Chattem, Inc. (US) | 2023-08-30 | — | — | EP | claimed |
| WO-2022087343-A1 | FOAMABLE COMPOSITION, USE THEREOF, AND PROCESS FOR ITS PREPARATION | CHATTEM, INC. (US) | 2022-04-28 | — | — | WO | claimed |
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CHICAGO ATLANTIC ADMIN, LLC | 2021-07-15 | — | — | US | claimed |
| EP-3169365-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OF ITCH | Westfälische Wilhelms-Universität Münster (DE) | 2017-05-24 | — | — | EP | claimed |
| EP-1924148-B1 | CONFECTIONERY COMPOSITION INCLUDING AN ELASTOMERIC COMPONENT, A COOKED SACCHARIDE COMPONENT, AND A SENSATE | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2016-07-20 | — | — | EP | claimed |
| US-20160128944-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME THERAPEUTICS LIMITED (IN) | 2016-05-12 | — | — | US | claimed |
| US-9320705-B2 | Sensation modifying topical composition foam | FOAMIX PHARMACEUTICALS LTD. (IL) | 2016-04-26 | — | — | US | claimed |
| EP-3003031-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | Vyome Biosciences Pvt Ltd (IN) | 2016-04-13 | — | — | EP | claimed |
| WO-2015169884-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OF ITCH | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (DE) | 2015-11-12 | — | — | WO | claimed |
| EP-1215257-B1 | Fragance composition | TAKASAGO PERFUMERY CO LTD (JP) | 2009-10-21 | — | — | EP | claimed |
| US-20080253973-A1 | SENSATION MODIFYING TOPICAL COMPOSITION FOAM | FOAMIX LTD. (IL) | 2008-10-16 | — | — | US | claimed |
| EP-1973422-A1 | COMPOSITIONS PROVIDING A HEATING SENSATION FOR ORAL OR DERMAL DELIVERY | Cadbury Adams USA LLC (US) | 2008-10-01 | — | — | EP | claimed |
| WO-2007126430-A1 | COMPOSITIONS PROVIDING A HEATING SENSATION FOR ORAL OR DERMAL DELIVERY | CADBURY ADAMS USA LLC (US) | 2007-11-08 | — | — | WO | claimed |
| US-20070178123-A1 | FLAVOR-ENHANCING COMPOSITIONS, METHOD OF MANUFACTURE, AND METHODS OF USE | KRAFT FOODS GLOBAL BRANDS LLC | 2007-08-02 | — | — | US | claimed |
| US-20070148103-A1 | Compositions providing a heating sensation for oral or dermal delivery | CADBURY ADAMS USA, LLC. | 2007-06-28 | — | — | US | claimed |
| US-6838106-B2 | Warming composition for food and drink or for oral care preparation | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-01-04 | — | — | US | claimed |
| US-6673844-B2 | REDUCING SKIN SENSITIVITY | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-01-06 | — | — | US | claimed |
| US-20020142015-A1 | Warming composition | TAKASAGO INTERNATIONAL CORPORATION | 2002-10-03 | — | — | US | claimed |
| EP-1215257-A2 | Warming composition | Takasago International Corporation (JP) | 2002-06-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070148103-A1 | Compositions providing a heating sensation for oral or dermal delivery | TAS2R8, TAS2R60, TAS2R20 | CYP1A2 2289/4885 |
| US-20020142015-A1 | Warming composition | CUTA, TRPA1, POLR1C | CYP1A2 135/4885 |
| US-20080253973-A1 | SENSATION MODIFYING TOPICAL COMPOSITION FOAM | TRPA1, GPR35, TRPV1 | CYP1A2 1644/4885 |
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CNR2, CNR1, CPNE4 | CYP1A2 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.